Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -28.91%30.04M | 28.76%123.29M | -10.65%42.25M | 63.42%95.75M | 83.50%70.41M | 123.10%47.29M | 262.29%23.81M | -63.47%58.59M | -69.92%38.37M | -76.40%21.2M |
| Operating income | -28.91%30.04M | 28.76%123.29M | -10.65%42.25M | 63.42%95.75M | 83.50%70.41M | 123.10%47.29M | 262.29%23.81M | -63.47%58.59M | -69.92%38.37M | -76.40%21.2M |
| Cost of sales | 26.96%-9.33M | 5.21%-25.46M | -0.09%-12.77M | -46.63%-26.85M | -61.79%-19.41M | -86.36%-12.76M | -234.66%-6.3M | 56.02%-18.31M | 63.38%-12M | 68.80%-6.85M |
| Operating expenses | 26.96%-9.33M | 5.21%-25.46M | -0.09%-12.77M | -46.63%-26.85M | -61.79%-19.41M | -86.36%-12.76M | -234.66%-6.3M | 56.02%-18.31M | 63.38%-12M | 68.80%-6.85M |
| Gross profit | -29.75%20.71M | 42.01%97.83M | -14.61%29.48M | 71.05%68.89M | 93.37%51M | 140.62%34.53M | 273.37%17.51M | -66.09%40.28M | -72.18%26.37M | -78.85%14.35M |
| Selling expenses | 85.12%-32K | -2,525.14%-9.19M | -49.31%-215K | -125.81%-350K | -71.54%-223K | -23.08%-144K | 72.48%-30K | 91.30%-155K | 91.57%-130K | 88.53%-117K |
| Profit from asset sales | ---- | -101.28%-322K | ---- | 53.15%25.15M | ---- | ---- | ---- | --16.42M | ---- | ---- |
| Employee expense | 37.77%-10.28M | 12.01%-31.39M | 7.35%-16.52M | -10.84%-35.68M | -15.13%-27M | -18.31%-17.83M | -20.08%-8.77M | 62.81%-32.19M | 65.50%-23.45M | 68.74%-15.07M |
| Depreciation and amortization | 29.85%-4.77M | 1.93%-13.02M | -2.66%-6.8M | 42.22%-13.27M | 50.14%-9.94M | 49.32%-6.62M | 50.83%-3.3M | 29.70%-22.97M | 23.30%-19.93M | 24.73%-13.06M |
| Revaluation surplus | ---- | 340.00%638K | ---- | -53.97%145K | ---- | ---799K | ---- | -44.15%315K | ---- | ---- |
| -Changes in the fair value of financial assets | ---- | 340.00%638K | ---- | -53.97%145K | ---- | ---- | ---- | 303.85%315K | ---- | ---- |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | ---799K | ---- | ---- | ---- | ---- |
| Impairment and provision | --1.83M | -1,099.18%-4.41M | ---- | 96.84%-368K | -837.50%-885K | -2,682.93%-1.06M | ---- | 45.45%-11.65M | 5,900.00%120K | 1,950.00%41K |
| -Impairment of property, machinery and equipment | ---244K | ---648K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | --2.07M | -923.10%-3.77M | ---- | 96.84%-368K | -837.50%-885K | -2,682.93%-1.06M | ---- | 45.45%-11.65M | 5,900.00%120K | 1,950.00%41K |
| Special items of operating profit | 19.93%-7.13M | -102.22%-49.94M | 14.63%-8.9M | 22.08%-24.7M | 63.82%-12.7M | 10.44%-10.43M | -20.12%-4.91M | 36.28%-31.7M | -40.86%-35.11M | 23.67%-11.65M |
| Operating profit | 111.22%331K | -149.45%-9.8M | -25.38%-2.95M | 147.61%19.83M | 100.48%251K | 90.78%-2.35M | 103.72%503K | 42.78%-41.65M | -103.33%-52.13M | -82.54%-25.5M |
| Financing cost | 7.21%-489K | 63.77%-1.35M | 29.45%-527K | 42.76%-3.73M | 70.76%-1.31M | 75.69%-747K | 77.44%-381K | 19.20%-6.52M | 29.47%-4.48M | 27.46%-3.07M |
| Share of profit from joint venture company | ---- | ---- | ---- | 99.61%-3K | ---- | ---- | ---- | -17.90%-764K | ---776K | ---669K |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---2.11M | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | 95.45%-158K | -169.34%-11.16M | -12.17%-3.48M | 132.88%16.09M | 94.47%-3.17M | 89.40%-3.1M | 100.80%122K | 39.96%-48.94M | -79.41%-57.38M | -60.62%-29.24M |
| Tax | ---- | ---- | ---- | ---183K | ---- | ---- | ---- | ---- | 121.74%5K | 183.33%5K |
| After-tax profit from continuing operations | 95.45%-158K | -170.14%-11.16M | -12.17%-3.48M | 132.51%15.91M | 94.47%-3.17M | 89.40%-3.1M | 100.80%122K | 39.98%-48.94M | -79.26%-57.38M | -60.54%-29.24M |
| Earning after tax | 95.45%-158K | -170.14%-11.16M | -12.17%-3.48M | 132.51%15.91M | 94.47%-3.17M | 89.40%-3.1M | 100.80%122K | 39.98%-48.94M | -79.26%-57.38M | -60.54%-29.24M |
| Minority profit | -926.08%-7.63M | -277.78%-1.79M | -205.08%-744K | 105.99%1.01M | 103.48%544K | 108.63%708K | 110.42%552K | -76.69%-16.84M | -196.47%-15.63M | -247.90%-8.21M |
| Profit attributable to shareholders | 373.65%7.48M | -162.86%-9.37M | 28.24%-2.73M | 146.42%14.9M | 91.10%-3.72M | 81.90%-3.81M | 95.66%-430K | 55.42%-32.09M | -56.15%-41.75M | -32.66%-21.03M |
| Basic earnings per share | 372.00%0.0136 | -142.12%-0.0171 | 83.39%-0.005 | 128.98%0.0406 | 93.41%-0.0121 | -223.66%-0.0301 | 95.45%-0.0002 | -304.91%-0.1401 | -1,301.53%-0.1836 | -16.25%-0.0093 |
| Diluted earnings per share | 372.00%0.0136 | -142.33%-0.0171 | 83.28%-0.005 | 128.84%0.0404 | 93.46%-0.012 | -221.51%-0.0299 | 95.35%-0.0002 | -304.91%-0.1401 | -1,404.92%-0.1836 | -24.00%-0.0093 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.